← back to search

Dominik Haim

Helmholtz-Zentrum Dresden-Rossendorf · DE
Area of research
Oral Surgery · Otorhinolaryngology
Research interest
Research interests include Head and Neck Cancer Studies, Dental Implant Techniques and Outcomes, Dental Radiography and Imaging, and Orthodontics and Dentofacial Orthopedics.
h-index
10
citations
300
works
36
NIH funding
primary concept
email

Recent publications

Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)—A Prospective Multicentric Cohort Study
Cancers 2023cited by 19position: middledoi
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts
Radiotherapy and Oncology 2023cited by 1position: middledoi
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy
Radiotherapy and Oncology 2022cited by 6position: middledoi
Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia
Acta Oncologica 2022cited by 5position: middledoi
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Cancers 2022cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Max Kemper · University Hospital Carl Gustav Carus1 papers (2022–2022)Korinna Jöhrens · University Hospital Carl Gustav Carus1 papers (2022–2022)Steffen Löck · German Cancer Research Center1 papers (2022–2022)Annett Linge · German Cancer Research Center1 papers (2022–2022)Karoline Leger · University Hospital Carl Gustav Carus1 papers (2022–2022)Noorazrul Yahya · Australian National University1 papers (2022–2022)Esther G.C. Troost · Heidelberg University1 papers (2022–2022)Mechthild Krause · German Cancer Research Center1 papers (2022–2022)Till Maile · German Cancer Research Center1 papers (2022–2022)